Setting new standards in information exchange for the pharmaceutical and biotech industry
Patients as Partners Opens in Europe this February in London
December 7, 2016
At the request of our European attendees at the Patients as Partners US event to bring the conference to Europe, we are delighted to announce we are doing just that on February 6-7, 2017 in London. Patients as Partners EU is co-produced with patients, industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement across the entire clinical development continuum. The US conference will take place March 2-3, 2017 in Philadelphia.
Each session at the 2017 conference seeks to put ideas into action and must demonstrate the what, where, when and how behind the topic. For example, when addressing the topic of, “How to Incorporate Patient Insights in Clinical Research,” the speaker representing AstraZeneca will show the planning, process and tools used to obtain the patient insights. They will also demonstrate how these insights were used to co-create solutions with patients and measure the impact of those initiatives.
Most of the sessions have at least one confirmed patient speaker to ensure the patient perspective is represented for the topic at hand.
Introducing “Ask the Patient”
We will introduce for the first time in Europe, the “Ask the Patient” program. This is an opportunity for attendees to meet face-to-face with patients who experienced at least one clinical trial. These patients, our Medical Heroes, will be attending the conference, providing a unique opportunity to learn about the realities of a clinical trial directly from the patient’s point of view. Opportunities to meet with patients will be both assigned and unassigned throughout the program.
“Patients Included” Accredited
Patients as Partners Europe is accredited by “Patients Included” (patientsincluded.org) to help address what matters most to patients to enable them to support clinical research. “Patients Included” provides a blueprint for:
– Understanding and incorporating the patient’s voice in designing clinical trials and developing a clinical endpoint
– Vastly improving the patient’s entire experience in a clinical trial
– Empowering the patient in the new medicines development process
Patients as Partners Europe is co-chaired by:
Clare Grace, PhD
VP, Site and Patient Access, INC Research
Anton Hoos, MD, PhD, MBA
Head of Medical, Amgen Europe
The goal of creating patient-centricity as the ecosystem within pharma cannot be achieved without patient involvement.
A special thanks to our patient, industry and academic advisors for their unwavering guidance and expertise in helping us develop an agenda that puts the “discussion” around patient involvement into action across the entire clinical development continuum. For more information, visit here or go to www.theconferenceforum.org. Take note there is a 15% launch discount off the first early bird with code PEUL15.